Characteristics, management and response to alteplase in China versus non-China participants of the ENCHANTED trial. [electronic resource]
Producer: 20210119Description: 53-58 p. digitalISSN:- 2059-8688
- Aged
- Aged, 80 and over
- Cerebral Hemorrhage -- chemically induced
- China -- epidemiology
- Disability Evaluation
- Female
- Fibrinolytic Agents -- administration & dosage
- Humans
- Infusions, Intravenous
- Ischemic Stroke -- diagnosis
- Male
- Middle Aged
- Prospective Studies
- Recovery of Function
- Risk Factors
- Thrombolytic Therapy -- adverse effects
- Time Factors
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.